ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.55
1.20%
US Tech 100
17,107.20
0.61%
Dow Jones
38,503.69
0.00%
Brent Oil
87.24
-0.37%
Bitcoin
66,619.70
0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. MEI Pharma Inc (MEIP) Quote

MEI Pharma Inc

MEI Pharma Inc (MEIP)

NASDAQ
3.3323
-0.04
(-1.12%)
Closed April 23 4:00PM
Delayed by 15 minutes
3.3323
0.00
( 0.00% )
Pre Market: 7:00AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.3323
Bid
3.00
Ask
3.58
Volume
-
0.00 Day's Range 0.00
3.20 52 Week Range 7.97
Market Cap
22.187M
Previous Close
3.3323
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
21,829
Shares Outstanding
6,662,857
Dividend Yield
-
PE Ratio
-0.70
Earnings Per Share (EPS)
-4.78
Revenue
48.82M
Net Profit
-31.84M

About MEI Pharma Inc

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve... MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.meipharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
MEI Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MEIP. The last closing price for MEI Pharma was $3.33. Over the last year, MEI Pharma shares have traded in a share price range of $ 3.20 to $ 7.97.

MEI Pharma currently has 6,662,857 shares outstanding. The market capitalization of MEI Pharma is $22.19 million. MEI Pharma has a price to earnings ratio (PE ratio) of -0.70.

MEIP Latest News

More News

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital...

April 11 2024
Business Wire

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping...

April 11 2024
Business Wire

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today...

April 10 2024
Business Wire

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

– Enrollment Initiated in 12-Patient Expansion Cohort Evaluating Voruciclib Plus Venetoclax in Ongoing Phase 1 Study – – Anti-leukemic Activity Across Multiple Heavily Pretreated Patients...

March 26 2024
Business Wire

Form EFFECT - Notice of Effectiveness

February 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 21 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

February 20 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 13 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.08232.532307692313.253.443.2118183.27949373CS
4-0.5477-14.11597938143.884.14733.2184233.67759458CS
12-1.3077-28.18318965524.644.973.2218294.00656266CS
26-3.8377-53.52440725247.177.87343.2357895.73259597CS
52-1.4777-30.72141372144.817.973.2443436.36629725CS
156-65.8677-95.184537572369.278.23.2126872419.60548408CS
260-58.0677-94.572801302961.491.53.2111867431.95430537CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.2988
(96.19%)
16.87M
AMSTAmesite Inc
$ 2.85
(42.50%)
1.9M
RILYB Riley Financial Inc
$ 28.61
(31.72%)
254.61k
IMCCIM Cannabis Corporation
$ 0.7268
(27.44%)
7
TSLRGraniteShares ETF Trust GraniteShares
$ 10.07
(24.17%)
6.11k
EVOEvotec SE
$ 5.25
(-31.37%)
144.24k
ESCAEscalade Inc
$ 10.35
(-24.78%)
11
TSDDGraniteShares ETF Trust GraniteShares
$ 26.911
(-24.19%)
22.76k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 42.65
(-23.73%)
302.36k
CDTGCDT Environmental Technology Investment Holdings Ltd
$ 3.03
(-19.41%)
22
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.2988
(96.19%)
16.87M
CYNCYNGN Inc
$ 0.114
(0.00%)
7.73M
ZPTAZapata Computing Holdings Inc
$ 1.83
(17.31%)
5.63M
PEGYPineapple Energy Inc
$ 0.0575
(1.59%)
5.07M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 6.67
(23.75%)
3.63M

MEIP Discussion

View Posts
chumfm chumfm 3 weeks ago
Raiders took all the cash with the dividend.Now the company share price is tanking,with no soft landing.No revenue streams and coffers are empty.Very difficult too see a bright future,here.All these trials take time and money.We will need an infusion of cash soon.Good luck and good trading.
👍️0
Monksdream Monksdream 4 weeks ago
MEIP under $5
👍️0
BurgerKing82 BurgerKing82 1 month ago
Pretty stagnant on this board for awhile ..Could be a good sign?
👍️0
philaya philaya 7 months ago
Sols some ...
No fun .
.
👍️0
philaya philaya 7 months ago
only 2 ask size 100 shares...
no selling all holding.
👍️0
philaya philaya 7 months ago
Added before er...
Easy bounce.
👍️0
kzivann kzivann 1 year ago
Out. May recover but R/S concern is here. Flip but still watching. Usually don't say much but since I told you I got some, figured I should.

MEIP
👍️0
kzivann kzivann 1 year ago
Doing a little. Risking a part of prior trades. Got only 1500 on that mini dip but didn't hit my larger .23 bid.


MEIP
👍️0
INFINITI INFINITI 1 year ago
What’s your take on Today thinking if loading
👍️0
kzivann kzivann 1 year ago
Lead drug. FDA issue. Continuing trails in Japan with partner. Has cash to continue with two other drugs here.

MEIP
👍️0
INFINITI INFINITI 1 year ago
Why did it drop so much
👍️0
kzivann kzivann 1 year ago
Bidding now. A little below current bid.

MEIP
👍️0
INFINITI INFINITI 1 year ago
Oops bottom cat bounce here
👍️0
INFINITI INFINITI 1 year ago
Biotin cat bounce here
👍️0
kzivann kzivann 1 year ago
Good move Friday $$$

MEIP
👍️0
rudyboy rudyboy 2 years ago
Who the fuck is selling all those shares.... institutions?
👍️0
kzivann kzivann 2 years ago
Little flips add up.

MEIP
👍️0
dfrank1988 dfrank1988 2 years ago
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
👍️0
kzivann kzivann 2 years ago
Again.

MEIP
👍️0
DD-214 DD-214 2 years ago
MEIP - MEI Pharma, Inc. (NASDAQ:MEIP) Shares Purchased by Sigma Planning Corp

Sigma Planning Corp lifted its holdings in MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) by 164.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 418,950 shares of the company’s stock after purchasing an additional 260,600 shares during the quarter. Sigma Planning Corp owned about 0.32% of MEI Pharma worth $252,000 as of its most recent SEC filing.

https://www.defenseworld.net/2022/07/11/mei-pharma-inc-nasdaqmeip-shares-purchased-by-sigma-planning-corp.html
👍️0
CAN8IENS CAN8IENS 2 years ago
I had a buddy tell me to buy this. Bought at .52. Completely forgot about it. What's up with the move?
👍️0
kzivann kzivann 2 years ago
Nice move.

MEIP
👍️0
Jess070283 Jess070283 2 years ago
Next huuuuge runner!!!
👍️0
kzivann kzivann 2 years ago
Keeps going up.

MEIP
👍️0
kzivann kzivann 2 years ago
Another nice move. Buy some, sell some, hold some.

MEIP
👍️0
kzivann kzivann 2 years ago
Dip but .51 not filled

MEIP
👍️0
kzivann kzivann 2 years ago
Premarket volume.

meip
👍️0
kzivann kzivann 2 years ago
Premarket volume.

meip
👍️0
Virgowhiteguy Virgowhiteguy 2 years ago
MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022

https://marketwirenews.com/news-releases/mei-pharma-and-kyowa-kirin-report-new-clinical-data--7831482843146987.html?t=389791
👍️0
kzivann kzivann 2 years ago
Again.

MEIP
👍️0
kzivann kzivann 2 years ago
Another nice bounce.

MEIP
👍️0
kzivann kzivann 2 years ago
Decent move..

MEIP
👍️0
kzivann kzivann 2 years ago
Very nice. Can MEIP breakout?
👍️0
kzivann kzivann 2 years ago
Bouncing off new low.

MEIP
👍️0
kzivann kzivann 2 years ago
Nice little run..

MEIP
👍️0
green maschine green maschine 2 years ago
Good morning $MEIP! In @ .64
👍️0
kzivann kzivann 2 years ago
Nice move. Occasionally lucky. Bought yesterday.

MEIP
👍️0
ErnieBilco ErnieBilco 2 years ago
But there may be hope after avg down

MEI Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $5.44, representing an 859.9% upside.
👍️0
ErnieBilco ErnieBilco 2 years ago
Very very poorly
👍️0
Bigstud is here Bigstud is here 2 years ago
Well, How your 98s work out?
👍️0
ErnieBilco ErnieBilco 2 years ago
Where is the bottom on this thing?
👍️0
DD-214 DD-214 2 years ago
Glutton for punishment.. back in @.537 average..
👍️0
DD-214 DD-214 2 years ago
Out @.589, lol that was quick.. i’ll keep an eye on it and jump back in when the timing is right..
👍️0
DD-214 DD-214 2 years ago
Took a new position on MEIP, 50k @.593 average.
👍️0
willlbone willlbone 2 years ago
MEIP MEIP roadrunner goes off the cliff.
👍️0
stockweiser stockweiser 2 years ago
The price is better
👍️0
ErnieBilco ErnieBilco 2 years ago
Ouch, 25% loss in less than a day - Guess .98 wasn't the right entry point last night.
👍️0
willlbone willlbone 2 years ago
Bid 50 cents
👍️0
ErnieBilco ErnieBilco 2 years ago
Well, Let's see how my .98s work out going forward from here.
👍️0
doczaius doczaius 4 years ago
Tipranks added them as one of their top smartscore stocks today. Need more eyes here along with volume
👍️0

Your Recent History

NASDAQ
MEIP
MEI Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved